Found: 5
Select item for more details and to access through your institution.
Overcoming resistance to anabolic SARM therapy in experimental cancer cachexia with an HDAC inhibitor.
- Published in:
- EMBO Molecular Medicine, 2020, v. 12, n. 2, p. N.PAG, doi. 10.15252/emmm.201809910
- By:
- Publication type:
- Article
Pharmacogenomics of statins: understanding susceptibility to adverse effects.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2016, v. 9, p. 97, doi. 10.2147/PGPM.S86013
- By:
- Publication type:
- Article
Oral Glucose Tolerance Test: An Informative Endpoint or an Added Burden in Metformin Drug–Drug Interaction Studies?
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 3, p. 453, doi. 10.1002/cpt.2650
- By:
- Publication type:
- Article
Approaches to handling missing or "problematic" pharmacology data: Pharmacokinetics.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2021, v. 10, n. 4, p. 291, doi. 10.1002/psp4.12611
- By:
- Publication type:
- Article
Pharmacokinetics, pharmacodynamics, and safety of GS‐3583, a FLT3 agonist Fc fusion protein, from single‐ascending‐dose phase I study in healthy participants.
- Published in:
- CTS: Clinical & Translational Science, 2024, v. 17, n. 8, p. 1, doi. 10.1111/cts.70011
- By:
- Publication type:
- Article